In several tumors (i.e., ESCA, LUSC, UCEC GBM, COAD, KIRP, CESC, and SARC), NACC1 expression varied depending on age, which, unfortunately, is not positive information for a potential diagnostic or therapeutic factor. Here, NACC1 is linked to glioblastoma.